[Impact of a clinical pathway for stroke patients].
OBJECTIVE
To assess the impact of the implementation of a clinical pathway for stroke patients.


METHODS
We performed a controlled intervention study without random allocation that compared two non-concomitant cohorts of stroke patients corresponding to the periods immediately before (control group) and after (intervention group) the implementation of a clinical pathway. The main outcome measures were: a) quality of care indicators; b) improvements in functional capacity (Barthel score) and neurological function (Canadian scale); c) nosocomial complications; d) satisfaction, and e) mean length of hospital stay.


RESULTS
One hundred and thirty-nine patients were recruited. Sixty-nine corresponded to the period before implementation of the pathway and 70 corresponded to the period after implementation. There were no significant differences between the two groups on admission. A 36.5% reduction in the time from admission to mobilization was observed. No significant differences were observed between the groups for the other quality of care indicators, or in improvements in functional and neurological capacity. Nosocomial complications occurred in 44.5% of patients in the control group compared with 28.6% in the intervention group (p = .039). No significant differences were observed in the overall satisfaction assessment, but patients in the intervention group showed greater satisfaction in the dimensions of "information" and "trust and professionalism". The mean length of hospital stay was reduced from 11 to 10 days.


CONCLUSIONS
The implementation of the stroke clinical pathway contributed to reducing the length of hospital stay and the number of inpatient complications, as well as to improving some quality of care indicators.
Esteve
Margarita
M
Dirección de Enfermería, Hospital de Mataró, Mataró, Barcelona, Spain.
Serra-Prat
Mateu
M
Zaldívar
Carme
C
Verdaguer
Albert
A
Berenguer
Joan
J
D000368:Aged; D000369:Aged, 80 and over; D015331:Cohort Studies; D015897:Comorbidity; D019091:Critical Pathways; D003428:Cross Infection / Q000150:complications; D005260:Female; D006801:Humans; D007902:Length of Stay; D008297:Male; D017060:Patient Satisfaction; D019984:Quality Indicators, Health Care; D013030:Spain; D020521:Stroke / Q000150:complications / Q000453:epidemiology / Q000628:therapy*